NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

In the News

CISION PR Newswire - February 26, 2026

Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences

CISION PR Newswire - April 24, 2024

TwinStrand Biosciences Initiates Regulatory Approval Process for Duplex Sequencing Mutagenesis Assays with OECD

SEATTLE PR Newswire - July 31, 2024

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology

CISION PR Newswire - November 15, 2023

Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents

CISION PR Newswire - August 29, 2023

TwinStrand Biosciences Announces Executive Leadership Changes to Accelerate Adoption of Duplex Sequencing for Minimal Residual Disease (MRD) Testing for Hematological Malignancies and Cell Therapy Monitoring

Business Wire - October 13, 2022

TwinStrand Biosciences Announces Leadership Transition

Globe Newswire - June 06, 2022

Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform

Business Wire - June 06, 2022

TwinStrand Biosciences to Showcase Recent Applications of its Duplex Sequencing Technology at the 2022 AGBT Annual Meeting

Life Science Washington - April 20, 2022

Life Science Innovation Northwest 2022

Our CEO, Jesse Salk MD, PhD will be speaking at the Life Sciences Innovation Northwest (LSINW) 2022 Convention during the Research Tools & Medical Device session.

Wednesday, April 20th, 2022 – 2:46pm PST

Inside Precision News - April 12, 2022

How Duplex Sequencing Can Improve MRD Detection: An Interview with Jesse Salk, MD, PhD, CEO of TwinStrand Biosciences

TwinStrand Biosciences - February 24, 2022

National Firefighter Cancer Symposium 2022

This year we were proud to sponsor the scientific workshop Applying Molecular Biology & Genetic Toxicology Methods to Improve Risk Assessment and Guide Risk Management Decisions for Cancer in Firefighters at the 2022 National Cancer Fire Symposium, hosted by the Firefighter Cancer Initiative (FCI).